The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
The diagnosis of primary biliary cirrhosis
Open accessAbstract
Primary biliary cirrhosis (PBC) is a chronic liver disease characterized by the immune mediated destruction of small intrahepatic bile duct epithelial cells leading to cholestasis and cirrhosis. The autoimmune basis of PBC is supported by the highly specific anti-mitochondrial antibodies (AMAs) and autoreactive T cells, the former being the basis for diagnosis in the vast majority of cases. Although a rare disease, the incidence rates of PBC have been increasing, possibly due to increased testing and diagnosis as opposed to a true increase in disease incidence. Presently, most cases are asymptomatic and only suspected based upon routine liver tests. Those with symptoms typically complain of pruritus and fatigue. The diagnosis of PBC is based on the presence of at least 2 of 3 key criteria including a persistently elevated serum alkaline phosphatase, the presence of serum AMAs, and liver histology consistent with PBC. Anti-nuclear antibodies specific to PBC are useful in cases in which AMAs are not detected and may indicate a more aggressive course. Ursodeoxycholic acid is the only proven therapy for PBC and in most cases can delay or prevent disease progression. However, a subgroup of patients does not adequately respond to ursodeoxycholic acid and for whom new therapies are needed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“The detection of the M2 type of anti-mitochondrial antibodies (that is, AMA-M2, often mistakenly referred to as ‘AMA’ by metonymy) is routinely performed in clinical settings as AMA-M2 positivity is a serological criterion for the diagnosis of PBC232.”
From The role of mitochondria in rheumatic diseases (2022) · cites this paper as [232]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
EASL Clinical Practice Guidelines: management of cholestatic liver diseases
European Association for the Study of the Liver (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.04.009 · Cited by 1,729
Schwab, M. (2011) · Springer eBooks · doi:10.1007/978-3-642-16483-5_4730 · Cited by 1,241
Lindor, K. D., Gershwin, E. M., Poupon, R., Kaplan, M., Bergasa, N. V., & Heathcote, J. E. (2009) · Hepatology · doi:10.1002/hep.22906 · Cited by 1,099
Prognosis in primary biliary cirrhosis: Model for decision making
Dickson, R. E., Grambsch, P. M., Fleming, T. R., Fisher, L. D., & Langworthy, A. (1989) · Hepatology · doi:10.1002/hep.1840100102 · Cited by 816 · cited 1×
“Several prognostic models have been developed with the Mayo risk model which includes age, total serum bilirubin, serum albumin, prothrombin time and severity of fluid retention, being the most widely accepted [37].”
Parés, A., Caballería, L., & Rodés, J. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.12.029 · Cited by 756
Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis)
Ludwig, J., Dickson, E. R., & McDonald, G. S. A. (1978) · Virchows Archiv A Pathological Anatomy and Histology · doi:10.1007/bf00432479 · Cited by 753
Chazouillères, O., Wendum, D., Serfaty, L., Montembault, S., Rosmorduc, O., & Poupon, R. (1998) · Hepatology · doi:10.1002/hep.510280203 · Cited by 746
Poupon, R., Lindor, K., Cauch-Dudek, K., Dickson, E., Poupon, R., & Heathcote, E. (1997) · Gastroenterology · doi:10.1016/s0016-5085(97)70183-5 · Cited by 648
Gershwin, E. M., Selmi, C., Worman, H. J., Gold, E. B., Watnik, M., Utts, J., Lindor, K. D., Kaplan, M. M., & Vierling, J. M. (2005) · Hepatology · doi:10.1002/hep.20907 · Cited by 621
Symposium: Advances in Liver Pathology [ Abridged ]
Scheuer, P. J. (1967) · Proceedings of the Royal Society of Medicine · doi:10.1177/003591576706001205 · Cited by 559
Flagged first, then by citations
Research works printed but not linked: 1
- Ray-Chadhuri, 2001, Epidemiology of PBC in Sheffield updated: demographics and relation to water supply, Gut, 48, 42
Cited by
Sorted by citations
Items 101–162 of 162
Shizuma, T. (2015) · Journal of Liver · doi:10.4172/2167-0889.1000186 · Cited by 4
A Concise Review of Autoimmune Liver Diseases
Than, N. N., & Oo, Y. H. (2015) · InTech eBooks · doi:10.5772/60520 · Cited by 4
Thymoquinone Protects Against EGCG/LPS Induced Hepatotoxicity in Mice
Saleh, I. G., Ali, Z., Wilson, F., Hamada, F. M. A., Abd‐Ellah, M. F., Walker, L., Khan, I. A., & Ashfaq, M. (2014) · International Journal of Pharmacology and Clinical Trials · doi:10.12817/20518293.26.1.27703355 · Cited by 4
АUTOANTIBODIES IN AUTOIMMUNE LIVER DISEASES (REVIEW OF LITERATURE)
Aleksandrova, E. N., Dorofeev, A. S., Novikov, A. A., & Sandler, Y. G. (2023) · Russian Clinical Laboratory Diagnostics · doi:10.51620/0869-2084-2023-68-8-464-474 · Cited by 3
Selmi, C. F. (2015) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-015-8504-9 · Cited by 3
Saleh, I. G., Ali, Z., Hammad, M., Wilson, F., Hamada, F. M., Abd‐Ellah, M. F., Walker, L., Khan, I., & Ashfaq, M. (2015) · Human & Experimental Toxicology · doi:10.1177/0960327115572707 · Cited by 3
Coexistence of Systemic Lupus Erythematosus and Primary Biliary Cirrhosis
Shizuma, T. (2014) · Journal of Clinical & Cellular Immunology · doi:10.4172/2155-9899.1000211 · Cited by 2
Rituximab Treatment in a Patient With Primary Biliary Cirrhosis and Rheumatoid Arthritis
Sargın, B., & GÜRER, G. (2016) · Archives of Rheumatology · doi:10.5606/archrheumatol.2016.5870 · Cited by 2
Geographical Disparity in Primary Biliary Cholangitis Prevalence: A Mini Review
Wibawa, I. D. N., & Shalim, C. P. (2022) · Gene Expression · doi:10.14218/ge.2022.00005 · Cited by 2
Souissi, S., Laabidi, S., Mustapha, N. B., Chelly, I., Serghini, M., Fekih, M., Laabidi, A., & Boubaker, J. (2024) · Future Science OA · doi:10.2144/fsoa-2023-0187 · Cited by 2
Reynolds Syndrome: a rare rheumatologic disease that internists should have in mind. Case report
Morantes-Caballero, J. A., Arenas, N. C., & de Narváez, J. F. R. (2017) · Case reports · doi:10.15446/cr.v3n1.59982 · Cited by 2
Amyotrophic Lateral Sclerosis and Primary Biliary Cirrhosis Overlap Syndrome: Two Cases Report
Zhang, H., Liu, Y., Li, Z., Liang, N., Zhou, X., Nie, X., Zhang, T., & Qi, W. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00890 · Cited by 3
Severe rhabdomyolysis following an uncomplicated endoscopic procedure: a case report
Tang, J. J., Park, K. S., Rajan, G. R., & Goldenberg, E. B. (2020) · Anaesthesia Pain & Intensive Care · doi:10.35975/apic.v24i3.1285 · Cited by 2
Gender-specific development of experimental autoimmune cholangitis induced by double-stranded RNA
Someya, S., Uchiyama, A., Arai, K., Kon, K., Yamashina, S., Watanabe, S., & Ikejima, K. (2021) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2021.12.011 · Cited by 2
Nakamori, A., Akagaki, F., Yamaguchi, Y., & Sugiura, T. (2020) · Internal Medicine · doi:10.2169/internalmedicine.4048-19 · Cited by 2
Lefkowitch, J. H. (2020) · Elsevier eBooks · doi:10.1016/b978-0-7020-7584-1.00005-x · Cited by 2
Health related quality of life in patients with primary biliary cholangitis
Yassin, F. A., Abiyev, A., Ergin, M., Ekmen, N., & İbi̇ş, M. (2022) · Journal of Clinical Medicine of Kazakhstan · doi:10.23950/jcmk/12292 · Cited by 1
Chang, M., Cheng, J., Le, P., Chen, W., Ku, H., & Chien, R. (2024) · Therapeutic Advances in Gastroenterology · doi:10.1177/17562848241241227 · Cited by 1
Systemic PCSK9 elevation characterises autoimmune liver disease across sexes
Mester, P., Pavel, V., Stöckert, P., Müller, M., Tews, H. C., & Buechler, C. (2025) · Scientific Reports · doi:10.1038/s41598-025-28881-y · Cited by 1
Romeo, M., Nardo, F. D., Basile, C., Napolitano, C., Vaia, P., Martinelli, G., Gregorio, A. D., Puorto, L. D., Indipendente, M., Dallio, M., et al. (2025) · Journal of Personalized Medicine · doi:10.3390/jpm15120597 · Cited by 2
Diagnostic potential of salivary biomarkers for primary biliary cholangitis: a systematic review
Saeed, M., Shaikh, M. S., Binhezaim, A., Almutairi, T. M., Lone, M. A., Bukhari, S. J. A., & Zafar, M. S. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2025.1670206 · Cited by 1
A multifaceted analysis of OTUD5 integrated MAVS in innate immunity of Primary Biliary Cholangitis
Chen, R., Sun, Y., & Tai, W. (2026) · PLoS ONE · doi:10.1371/journal.pone.0342306 · Cited by 1
Sex disparities in primary biliary cholangitis: insights from a Japanese multicentre cohort
Nguyen, Q. T., Yoshimura, K., Takahashi, K., Yang, R., Kimura, T., Okumura, T., Kawata, K., Joshita, S., & Harada, K. (2026) · Medical Molecular Morphology · doi:10.1007/s00795-026-00475-1 · Cited by 1
Morgan, T., Qayyum, A., & Gore, R. M. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-5117-4.00089-1 · Cited by 1
Zárate-Pinzón, L., Flórez‐Esparza, G., Rodríguez-Rodríguez, C. A., Diez-Bahamón, L. A., Mejía‐Salgado, G., Cifuentes‐González, C., & de‐la‐Torre, A. (2024) · Ocular Immunology and Inflammation · doi:10.1080/09273948.2024.2333391 · Cited by 1
Immunological and fibrotic profiling in the NOD.c3c4 murine model of autoimmune cholangitis
Nanjundappa, R. H., Kolla, H. B., Edgar, A. J., Leung, P. S. C., Chauhan, D. S., Ridgway, W. M., Gershwin, M. E., & Umeshappa, C. S. (2025) · Journal of Autoimmunity · doi:10.1016/j.jaut.2025.103473 · Cited by 1
Self-citationTowards the serological diagnosis of primary biliary cirrhosis
Vergani, D. (2014) · Liver International · doi:10.1111/liv.12732 · Cited by 1
Samat, M. N. A., Wahab, A. A., Ding, C. H., Mohammad, M., Biswas, S., & Rahman, M. M. (2015) · PubMed Central · doi:10.17179/excli2014-660 · Cited by 1
Primary Biliary Cirrhosis and Ankylosing Spondylitis, A Rare Association
Emese-Katalin, K., István, B., Enikő, G., & Julianna, B. A. (2018) · Internal Medicine · doi:10.2478/inmed-2018-0045 · Cited by 1
Ge, S., Xu, Q., Li, H., Shao, T., Zhong, F., Leung, P. S. C., & Shuai, Z. (2022) · Liver International · doi:10.1111/liv.15360 · Cited by 1
Immunomodulators and Autoimmune Liver Diseases
Anirudh, K. V. S., & Kandra, P. (2022) · Springer eBooks · doi:10.1007/978-981-16-6379-6_8 · Cited by 1
Orphan drugs in development for primary biliary cirrhosis: challenges and progress
Lindor, K. D., Ali, A. H., & Byrne, T. (2015) · Orphan Drugs Research and Reviews · doi:10.2147/odrr.s69477
Coexistence of Primary Biliary Cirrhosis and Immune Thrombocytopenic Purpura
Shizuma, T. (2015) · Journal of Gastrointestinal & Digestive System · doi:10.4172/2161-069x.1000273
A Literature Review of Concomitant Primary Biliary Cirrhosis and Graves’ Disease
Shizuma, T. (2015) · Journal of Gastrointestinal & Digestive System · doi:10.4172/2161-069x.1000269
Autoimmune Liver Diseases: Primary Biliary Cholangitis
Ali, A. H., Carey, E. J., & Lindor, K. D. (2016) · Springer eBooks · doi:10.1007/978-3-319-30103-7_16
Shizuma, T. (2014) · Journal of Gastrointestinal & Digestive System · doi:10.4172/2161-069x.1000303
PRIMARY SJOGREN'S SYNDROME ASSOCIATED WITH ANTICENTROMERE ANTIBODIES
Chaltsev, B. D. (2018) · Rheumatology Science and Practice · doi:10.14412/1995-4484-2018-235-238
Primary biliary cholangitis: an update on treatment
Bibi, F. (2018) · Gastrointestinal Nursing · doi:10.12968/gasn.2018.16.sup10.s10
Primary Biliary Cholangitis in a Male: A Rare Case
Thakur, R. (2018) · Journal of Gastrointestinal & Digestive System · doi:10.4172/2161-069x.1000579
Chronic elevated liver enzymes with ABCB11 mutation in healthy adult twin males: A case report
Fares, A., Landmann, T., charisius, C., charisius, C., & Christoph charisius: Hausaerztliche Gemeinschaftspraxsis, P. G. (2017) · The Journal of Medical Research · doi:10.31254/jmr.2017.3107
Role of regulatory T cells in pathogenesis and therapy of autoimmune liver disease
Sun, M., & Liu, W. (2019) · World Chinese Journal of Digestology · doi:10.11569/wcjd.v27.i11.665
Verbesserte Prognose, aber limitierte Therapieoptionen für PBC und PSC
Koenen, M. T., Zimmermann, H. W., & Trautwein, C. (2019) · Gastro-News · doi:10.1007/s15036-019-0633-1
Lajouad, S., Bouziane, A., Benelbaghdadi, I., Berhili, K., Lagdali, N., Borahma, M., & Ajana, F. Z. (2019) · Saudi Journal of Medical and Pharmaceutical Sciences · doi:10.36348/sjmps.2019.v05i11.004
How to advise on safe delivery and best contraception for patients with heart failure
Johnson, M. R., & Cauldwell, M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-817667-2.00007-4
Tokyo Designer's Week: amor sin destino
Pirrone, S. (2007) · Diseño interior
Lefkowitch, J. H. (2016) · Elsevier eBooks · doi:10.1016/b978-0-7020-5548-5.00005-0
Inflammatory Disorders of the Biliary Tract
Yeh, B. M., & Chang, W. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-5117-4.00080-5
Mohamed, A. A., Mekky, M. A. E. S. M., El-Wafa, Y. H. A., & Abu-Elfatth, A. M. (2022) · The Egyptian Journal of Hospital Medicine · doi:10.21608/ejhm.2022.244528
Terapias usuales y emergentes en colangitis biliar primaria
Díaz-Duque, J. C., Palacio-Valencia, V., Suárez-Meneses, J., Montaña-López, J. A., & Palacio-Sánchez, E. (2022) · Hepatología · doi:10.52784/27112330.156
Celińska‐Löwenhoff, M., Iwaniec, T., Dziedzina, S., Kaczor, M. P., Pastuszczak, M., Dropiński, J., Sanak, M., & Musiał, J. (2023) · Research Square · doi:10.21203/rs.3.rs-2858961/v1
Jaramillo, P. A., Ibrahimli, S., & Castells, J. (2023) · Cureus · doi:10.7759/cureus.39517
Primary Biliary Cirrhosis Scenario of Libyan Patients in Tripoli University Hospital
Omar, S., Diekna, W. A. A., Allafi, M. M., & Torjman, F. (2023) · Libyan Journal of Medical Research · doi:10.54361/ljmr.17-04
Cholestasis and Biliary Tract Disorders
Kanel, G. C. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-82533-7.00004-1
Primary biliary cholangitis in Thai woman: A case report (P. 105)
Sanglutong, L. (2020) · Chulalongkorn Medical Journal · doi:10.58837/chula.cmj.64.1.11
Metabolomics-based Investigation of Primary Biliary Cholangitis: A Cholestatic Liver DiseasePreprint
de Oliveira, J. M., Lopes, T. D. A., Castro, A., Signini, É. D. F., Catai, A. M., Ferreira, A. G., Cançado, E. L. R., & Oliveira, R. V. (2024) · Research Square · doi:10.21203/rs.3.rs-3898120/v1
Shaik, M. R., Jung, H. J., Shaik, N. A., & Mikdashi, J. A. (2024) · Indian Journal of Rheumatology · doi:10.1177/09733698241300754
Thakkar, H. H., Mathew, N. V., Reddy, E. P., Cheetiyar, A. L., Kommalapati, V., Mathew, A., Rajendiran, A., Riyaz, R., Joseph, N., Obadi, A. H., et al. (2025) · Cureus · doi:10.7759/cureus.82008
Chen, R., Huang, X., Wang, Y., Wang, T., Ouyang, R., & Hou, H. (2025) · Laboratory Medicine · doi:10.1093/labmed/lmaf049
Du, Q., Han, Y., & Pan, P. (2025) · Medicine · doi:10.1097/md.0000000000044731
Ortega-Torres, A., Sánchez-Díaz, G., Villaverde‐Hueso, A., Arias-Merino, G., & Alonso‐Ferreira, V. (2026) · BMC Public Health · doi:10.1186/s12889-026-28178-3
Wei, W., Xu, X., Xiao, H., Zuo, Z., Xiang, X., Fang, Z., & Tan, Y. (2026) · IEEE Internet of Things Journal · doi:10.1109/jiot.2026.3707559
Sanai, F. M., Alghamdi, A. S., Khathlan, A. A., Qutub, A. A., Quraishi, H. A., Alghamdi, M., ALZaabi, M. E. H., Mawardi, M., Altarrah, M. Y., Alnahdi, N., et al. (2026) · Cureus · doi:10.7759/cureus.113526
Metadata
- Authors
- Bowlus, C. L., & Gershwin, M. E.
- Affiliations
- University of California, Davis (US)
- Corresponding author
- Bowlus, Christopher L.
- Venue
- Autoimmunity Reviews
- Publisher
- Elsevier BV
- Published
- 2014-04
- Volume
- 13
- Issue
- 4-5
- Pages
- 441-444
- ISSN
- 1568-9972 (ISSN-L)
- PMC
- PMC3987745
- OpenAlex
- W2060770061
- Cited by
- 162
- References
- 67
- Citations by year
- 2026: 6 · 2025: 8 · 2024: 7 · 2023: 10 · 2022: 15 · 2021: 9 · 2020: 12 · 2019: 15 · 2018: 13 · 2017: 12 · 2016: 14 · 2015: 25 · 2014: 14
- FWCI
- 2.88
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Autoimmunity Reviews (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK039588)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Health Sciences › Medicine › Surgery › Pediatric Hepatobiliary Diseases and Treatments
- Health Sciences › Medicine › Rheumatology › IgG4-Related and Inflammatory Diseases
- Keywords
- primary biliary cirrhosis, diagnosis, antimitochondrial antibodies, autoantibodies, cholestasis, autoimmune liver disease, alkaline phosphatase, liver histopathology, antinuclear antibodies, ursodeoxycholic acid, disease progression, incidence
- MeSH terms
- Animals, Antibodies, Diagnosis, Differential, Humans, Liver Cirrhosis, Biliary, Mitochondria, Hepatitis, Autoimmune
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
